Denali Therapeutics Inc. (DNLI) PT Raised to $40 at Goldman Sachs
Tweet Send to a Friend
Goldman Sachs analyst Salveen Richter raised the price target on Denali Therapeutics Inc. (NASDAQ: DNLI) to $40.00 (from $35.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
